SHELLEY MILES: Open Payments
NPI 1265788343 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,146 in 162 payments from 26 companies in 2025. Trend: 2023 $5,436 · 2024 $13,530 · 2025 $13,146
Speaker / faculty: $7,445Food & beverage: $3,687Travel & lodging: $1,156Consulting: $757Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 23 | $10,260 |
| Daiichi Sankyo Inc. | 67 | $842 |
| Incyte Corporation | 4 | $313 |
| Novartis Pharmaceuticals Corporation | 14 | $236 |
| BeOne Medicines USA, Inc. | 3 | $191 |
| Janssen Biotech, Inc. | 9 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $124 |
| Merck Sharp & Dohme LLC | 4 | $113 |
| Gilead Sciences, Inc. | 4 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $109 |
Products named: LIBTAYO, Enhertu, JAKAFI, DATROWAY, KISQALI, TEVIMBRA, RYBREVANT, Nubeqa.
Industry payments across NV — which companies pay providers there.
